Search clinical trials for: AIGIV
Total 45 results
-
Emergent BioSolutionsDepartment of Health and Human Services; Centers for Disease Control and PreventionNot yet recruiting
-
Emergent BioSolutionsDepartment of Health and Human Services; Centers for Disease Control and PreventionNot yet recruiting
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
Grifols Therapeutics LLCCompletedMyasthenia GravisUnited States, Belgium, Czechia, Estonia, Canada, France, Germany, Hungary, Poland, Lithuania
-
Versailles HospitalUnknown
-
Instituto Grifols, S.A.CompletedImmune (Idiopathic) Thrombocytopenic PurpuraSpain, Russian Federation, United Kingdom
-
Grifols Therapeutics LLCCompletedA Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis ExacerbationsBelgium, Poland, Canada, Argentina, Estonia, France, Hungary, Romania, Czechia, Latvia, Russian Federation, South Africa
-
Grifols Therapeutics LLCCompletedMyasthenia Gravis, GeneralizedUnited States, Belgium, Czechia, Canada, Estonia, Lithuania, France, Germany, Hungary, Poland
-
Emergent BioSolutionsUnited States Department of DefenseCompleted
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedCongenital Cytomegalovirus Infection | Maternal Cytomegalovirus InfectionUnited States
-
SeqirusCompletedInfluenza, HumanUnited States
-
Emergent BioSolutionsCompletedInfluenza A H3N2 | Influenza A H1N1United States, Spain, Canada, Puerto Rico
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
-
Grifols Therapeutics LLCCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Therapure Biopharma IncUnknownPrimary Immune Deficiency Diseases (PIDD)United States, Canada
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
Grifols Therapeutics LLCCompletedCommon Variable Immunodeficiency | Severe Combined Immunodeficiency | Wiskott-Aldrich Syndrome | Agammaglobulinemia | Immunologic Deficiency SyndromeCanada, United States
-
University of TennesseeCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Green Cross CorporationWithdrawnPrimary Immune Deficiency Disorder
-
Baxalta now part of ShireAlzheimer's Disease Cooperative Study (ADCS)CompletedAlzheimer´s DiseaseUnited States, Canada
-
Emergent BioSolutionsCenters for Disease Control and PreventionEnrolling by invitationComplication of Smallpox Vaccination
-
Grifols Therapeutics LLCCompletedImmunologic Deficiency SyndromeUnited States, Canada
-
Baxalta now part of ShireCompleted
-
FFF EnterprisesOMRIX BiopharmaceuticalsCompletedImmunologic Deficiency SyndromesUnited States, Canada
-
ADMA Biologics, Inc.CompletedPrimary Immune Deficiency Disorders (PIDD)United States
-
Baxalta now part of ShireTerminatedAlzheimer´s DiseaseUnited States, Poland, United Kingdom, Belgium, Spain, Japan, Canada, Australia
-
Grifols Therapeutics LLCCompletedMacular DegenerationGermany
-
Beth Israel Deaconess Medical CenterGrifols Biologicals, LLCTerminatedDiabetes Mellitus | Diabetes Complications | Diabetic NeuropathiesUnited States
-
Green Cross CorporationParexel; Atlantic Research GroupCompletedImmunologic Deficiency SyndromesCanada, United States
-
Baxalta now part of ShireTerminated
-
Green Cross CorporationAtlantic Research GroupRecruitingPrimary Immune DeficiencyUnited States
-
University of ChicagoSunnybrook Health Sciences Centre; University of British Columbia; University... and other collaboratorsCompletedAbortion, Habitual | Miscarriage, RecurrentUnited States
-
Ottawa Hospital Research InstituteCSL Behring; Grifols Biologicals, LLCCompleted
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Japan
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Baxalta now part of ShireCompleted
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencyUnited States, Canada
-
Green Cross CorporationAtlantic Research GroupCompletedImmunologic Deficiency SyndromeUnited States, Canada
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Baxalta now part of ShireCompletedMultifocal Motor NeuropathyUnited States, Canada, Denmark
-
Assistance Publique - Hôpitaux de ParisRecruitingImmune Thrombocytopenia (ITP)France
-
Seoul National University Bundang HospitalYuhan CorporationCompletedCoronary Artery Disease | Diabetes Mellitus | Renal Insufficiency, ChronicKorea, Republic of
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia